U.S. Court Overturns Bid By India's Ranbaxy Laboratories To Block Launch Of Rival Generic Drugs

A U.S. court has denied a request by Indian drugmaker Ranbaxy Laboratories Ltd to stop competitors from launching copies of AstraZeneca Plc's heartburn pill Nexium and Roche's antiviral Valcyte, a court filing showed.

Ranbaxy had sought the restraining order against Dr Reddy's Laboratories and U.S. firm Endo International Plc in a lawsuit it filed against the U.S. Food and Drug Administration last week for revoking tentative approvals to launch Nexium and Valcyte copies in the United States, its largest market.

Help employers find you! Check out all the jobs and post your resume.

Back to news